Mark Creager, MD, president of the American Heart Association, interviews Joey Granger, PhD, program chair of Hypertension 2015, about the science that will be presented during the meeting in Washington, DC, including a keynote lecture by Gary Gibbons of the NHLBI and more.

Mark Creager, MD, president of the American Heart Association, and Mariell Jessup, MD, discuss OptiLink HF and SERVE-HF which were presented in Hot Line V on Heart Failure at the European Society of Cardiology Congress 2015.

Mark Creager, MD, president of the American Heart Association, and Kim Allan Williams, Sr, MD, president of the American College of Cardiology, review some of the highlights of the science presented this week at the European Society of Cardiology Congress 2015.

Mark Creager, MD, president of the American Heart Association, and Elliott Antman, MD discuss trials presented at Hot Line VI on Coronary Artery Disease at the European Society of Cardiology Congress 2015, including PRESERVATION I, ABSORB STEMI TROFI II, and ABSORB Japan.

Mariell Jessup, MD and Mark Creager, MD, president of the American Heart Association, review the some of the science presented in Hot Line IV at the European Society of Cardiology Congress 2015 in London, including PATHWAY-2, PATHWAY-3 and PARAMETER.

Mark Creager, MD, president of the American Heart Association, and Mariell Jessup, MD review some of the science presented at Hot Line III at the European Society of Cardiology Congress 2015 in London, including SCOT, TECOS, and ELIXA.

Mark Creager, MD, president of the American Heart Association and Bob Bonow, MD and Elliott Antman, MD, both past presidents review the science on acute myocardial infarction presented in Hotline I at the European Society of Cardiology Congress 2015 in London, including DOPPLER-CIP, ALBATROSS, and CIRCUS.

Mark Creager, MD, president of the American Heart Association and Bob Bonow, MD and Elliott Antman, MD, both past presidents, discuss the Atrial Fibrillation and Pacing science presented in Hotline II at the European Society of Cardiology Congress 2015 in London, including LEADLESS II and BELIEF.

Sakthivel Sadayappan, PhD, and Yibin Wang, PhD, provide a preview of some of the science that will be presented at the final scientific session for BCVS 2015 on the genetics of cardiac development and disease, which will looks at the interaction of genetics and the environment in the context of heart failure.

Lorrie Kirshenbaum, PhD, chair of the Early Career Committee for Basic Cardiovascular Sciences (BCVS) 2015 Scientific Sessions, talks with Johannes Backs, one of the finalists for the 2015 BCVS Outstanding Early Career Award about his study, "Disrupting the Interaction Between CaM Kinase II and Histone Deacetylase 4--an Epigenetic Therapy for Heart Failure."